GRAY MARY ANN has filed 40 insider transactions across 5 companies since February 2023.
Most recent transaction: a disposition of 938 shares of RAPT Therapeutics, Inc. ($RAPT) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 938 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 32229 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.12% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 478 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 7650 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.03% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 4561 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.02% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | U | Common Stock | 4956 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.02% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 2813 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.01% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 1072 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 1618 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.01% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 498 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 938 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 560 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 1063 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| March 3, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | D | Director Stock Option (right to buy) | 484 | $0.00 | 0.0000 | 27,710,871 | 100.00% | 0.00% |
| Jan. 30, 2026 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | A | Common Stock | 4956 | $0.00 | 4,956.0000 | 27,710,871 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| June 18, 2025 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Not found | A | Common Stock | 23500 | $0.00 | 77,397.0000 | 58,099,164 | 43.60% | 0.04% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | GRAY MARY ANN | Not found | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 37,437,652 | 9999.99% | 0.03% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | GRAY MARY ANN | Not found | A | Common Stock | 5250 | $0.00 | 5,250.0000 | 37,437,652 | 9999.99% | 0.01% |
| May 29, 2025 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | A | Director Stock Option (right to buy) | 257832 | $0.00 | 257,832.0000 | 132,006,828 | 9999.99% | 0.20% |
| March 31, 2025 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | A | Director Stock Option (right to buy) | 61202 | $1.06 | 61,202.0000 | 132,006,828 | 9999.99% | 0.05% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Not found | A | Common Stock | 16500 | $0.00 | 53,897.0000 | 48,077,599 | 44.12% | 0.03% |
| May 30, 2024 | Keros Therapeutics, Inc. | $KROS | GRAY MARY ANN | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 29,447,119 | 9999.99% | 0.03% |
| May 22, 2024 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | A | Stock Option (right to buy) | 36490 | $0.00 | 36,490.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Not found | A | Stock Option (right to buy) | 8574 | $7.58 | 8,574.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2023 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Director | A | Common Stock | 5995 | $0.00 | 37,397.0000 | 0 | 19.09% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | GRAY MARY ANN | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | GRAY MARY ANN | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2023 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Director | A | Common Stock | 8676 | $0.00 | 31,402.0000 | 0 | 38.18% | 0.00% |
| June 30, 2023 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Director | A | Common Stock | 4916 | $0.00 | 22,726.0000 | 0 | 27.60% | 0.00% |
| June 14, 2023 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | PALISADE BIO, INC. | $PALI | GRAY MARY ANN | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | PALISADE BIO, INC. | $PALI | GRAY MARY ANN | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Keros Therapeutics, Inc. | $KROS | GRAY MARY ANN | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 25,241,030 | 9999.99% | 0.04% |
| May 24, 2023 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Director | A | Stock Option (right to buy) | 12940 | $0.00 | 12,940.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | BioAtla, Inc. | $BCAB | GRAY MARY ANN | Director | A | Common Stock | 5503 | $0.00 | 17,810.0000 | 0 | 44.71% | 0.00% |
| March 31, 2023 | RAPT Therapeutics, Inc. | $RAPT | GRAY MARY ANN | Director | A | Stock Option (right to buy) | 4477 | $14.52 | 4,477.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |